A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Atovaquone

DRUG

Pentamidine isethionate

Trial Locations (20)

10003

Beth Israel Med Ctr, New York

10011

Saint Vincent's Hosp and Med Ctr, New York

10037

Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York

19107

Buckley Braffman Stern Med Associates, Philadelphia

30345

Infectious Disease Research Consortium of Georgia, Atlanta

38103

Regional Med Ctr at Memphis, Memphis

77004

Gathe, Joseph, M.D., Houston

77030

Baylor College of Medicine, Houston

90048

Cedars Sinai Med Ctr, Los Angeles

90095

UCLA CARE Ctr, Los Angeles

90710

Kaiser Foundation Hosp, Harbor City

92668

UCI Med Ctr, Orange

94063

AIDS Community Research Consortium, Redwood City

94114

Davies Med Ctr, San Francisco

94583

Dr Patrick Joseph, San Ramone

94704

East Bay AIDS Ctr, Berkeley

97210

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

452670405

Univ of Cincinnati, Cincinnati

02114

Massachusetts Gen Hosp, Boston

02118

Boston City Hosp, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY